| Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) (NCT03797326) | Merck Sharp & Dohme LLC | 2019-02-12 |
| Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study (NCT03978481) | Seoul National University Bundang Hospital | 2019-01-30 |
| A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies (NCT03829501) | Kymab Limited | 2019-01-28 |
| Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer (NCT03817411) | Taizhou EOC Pharma Co., Ltd. | 2019-01-25 |
| Biomarker Study of PDR001 in Combination With MCS110 in Gastric Cancer (NCT03694977) | Seoul National University Hospital | 2019-01-17 |
| Capecitabine or Observation for Patients With pT1N+M0 or pT2-3N0M0 Gastric Adenocarcinoma Undergoing R0 Resection (NCT03817268) | The First Affiliated Hospital of Anhui Medical University | 2019-01-16 |
| The Diagnostic Value of Staging Laparoscopy and Computed Tomography Response Assessment in Patients With Gastric Adenocarcinoma (NCT05013775) | Sander van Hootegem | 2019-01-15 |
| Comparison Between Double Tract Anastomosis and Esophagogastrostomy After Radical Proximal Gastrectomy (NCT03613142) | Peking University Cancer Hospital & Institute | 2019-01-01 |
| The Research of Constructing a Risk Assessment Model for Gastric Cancer Based on Machine Learning (NCT04957407) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2019-01-01 |
| S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC） (NCT03941561) | Fudan University | 2019-01-01 |
| Effect of Pneumoperitoneum on the Continuous and Non-invasive Hemoglobin Monitoring (NCT03430778) | Ajou University School of Medicine | 2019-01-01 |
| A Trial of Total Versus Partial Omentectomy for Advanced Gastric Cancer in Gastrectomy (NCT04108494) | Tianjin Medical University Cancer Institute and Hospital | 2019-01-01 |
| Study About no Antimicrobial Prophylaxis in Totally Laparoscopic Distal Gastrectomy (NCT03802097) | Korean South West East Gastric Surgery Group | 2018-12-27 |
| TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (NCT03686488) | H. Lee Moffitt Cancer Center and Research Institute | 2018-12-20 |
| Effect of Lymph Node Ratio in Gastric Cancer to Determine Recurrence Rate After Curative Resection (NCT03778710) | Mahidol University | 2018-12-18 |
| QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors (NCT03228667) | ImmunityBio, Inc. | 2018-12-11 |
| Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients (NCT03787056) | Hospices Civils de Lyon | 2018-12-04 |
| A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation (NCT04308837) | Icahn School of Medicine at Mount Sinai | 2018-12-03 |
| Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients (NCT03760822) | Federation Francophone de Cancerologie Digestive | 2018-11-16 |
| A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors (NCT03734926) | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | 2018-11-13 |
| Study of ADCT-301 in Patients With Selected Advanced Solid Tumors (NCT03621982) | ADC Therapeutics S.A. | 2018-11-09 |
| Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer (NCT06204523) | Regina Elena Cancer Institute | 2018-10-26 |
| Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies (NCT03539822) | Anwaar Saeed | 2018-10-22 |
| An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers (NCT03662659) | Bristol-Myers Squibb | 2018-10-16 |
| Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site (NCT03716089) | Fujian Medical University | 2018-10-11 |
| Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples (NCT03721042) | Nouvelle Clinique Bonnefon | 2018-10-11 |
| Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer (NCT06490159) | City of Hope Medical Center | 2018-10-01 |
| A Study to Evaluate Safety, Tolerability, and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced Gastric or Gastroesophageal Junction Cancer (NCT03707028) | Elevar Therapeutics | 2018-10-01 |
| Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy (NCT03680261) | Shanghai Zhongshan Hospital | 2018-10-01 |
| Predicting the Efficacy in Advanced Gastric Cancer. (NCT06490055) | City of Hope Medical Center | 2018-10-01 |
| PAN-study: Pan-Cancer Early Detection Study (PAN) (NCT03756597) | Owlstone Ltd | 2018-09-26 |
| A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies (NCT03652077) | Incyte Corporation | 2018-09-24 |
| Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancer (NCT03619681) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2018-09-17 |
| Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With GC/GEJ and High Immune Responsiveness (NCT03421288) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2018-09-14 |
| A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer (NCT03694522) | Five Prime Therapeutics, Inc. | 2018-09-14 |
| CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC) (NCT03682744) | Sorrento Therapeutics, Inc. | 2018-09-13 |
| Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors (NCT03511222) | Washington University School of Medicine | 2018-09-11 |
| Anastomotic Leak Testing in Gastrectomy (NCT04292496) | Nanchong Central Hospital | 2018-09-01 |
| Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer (NCT03636893) | Ruijin Hospital | 2018-08-24 |
| HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo Surgery (NCT03642093) | Siobhan Trotter | 2018-08-01 |
| Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy (NCT03609892) | Xijing Hospital of Digestive Diseases | 2018-08-01 |
| The GAstric Precancerous Conditions Study (NCT04191551) | Stanford University | 2018-07-30 |
| Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric Cancer (NCT03601988) | Huazhong University of Science and Technology | 2018-07-28 |
| Study to Evaluate SHR6390 Combined With Pyrotinib in Patients With HER2 Positive Gastric Cancer (NCT03480256) | Peking University | 2018-07-27 |
| Kinetics of Microparticles Under Chemotherapy in Patients With Gastric or Pancreatic Cancer (NCT03471468) | Poitiers University Hospital | 2018-07-23 |
| A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer Subjects With the Overexpression of HER2 (NCT03556345) | RemeGen Co., Ltd. | 2018-07-10 |
| mFLOT Chemotherapy as First-line Treatment in GC (NCT03606928) | Ruijin Hospital | 2018-07-01 |
| Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for AGC (NCT03708783) | Peking University Cancer Hospital & Institute | 2018-07-01 |
| Study Maintenance Regorafenib vs Placebo, no Progression Patients After I Line Chemotherapy Metastatic Gastric Cancer (NCT03627728) | Gruppo Oncologico Italiano di Ricerca Clinica | 2018-06-13 |
| Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy (NCT03515356) | University of Michigan Rogel Cancer Center | 2018-06-13 |
| A Study of IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma (NCT03528629) | Astellas Pharma Inc | 2018-06-08 |
| A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer (NCT03597581) | Inspirna, Inc. | 2018-06-05 |
| The Bacterial Composition of the Stomach in Reflux Disease (NCT03835663) | Imperial College London | 2018-06-04 |
| Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos (NCT03668418) | University of Pisa | 2018-06-01 |
| Procalcitonin to Predict Infection After Gastrectomy for Gastric Cancer (NCT03780439) | Yongchang Zhang | 2018-06-01 |
| Safety and Efficacy of OGT Method Versus the Traditional Overlap Method (NCT05442502) | Nanfang Hospital, Southern Medical University | 2018-06-01 |
| Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. (NCT03525392) | Ipsen | 2018-05-03 |
| A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors (NCT03526835) | Merus B.V. | 2018-05-02 |
| GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors (NCT03576131) | Genmab | 2018-04-30 |
| Robotic and Laparoscopic Total Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer (NCT03500471) | Southwest Hospital, China | 2018-04-16 |
| Trial for Application of Laparoscopic Total Gastrectomy With Lymph Node Dissection for Gastric Cancer (KLASS-06) (NCT03385018) | Yonsei University | 2018-04-05 |
| A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer (NCT03472365) | Jiangsu HengRui Medicine Co., Ltd. | 2018-04-02 |
| Intestinal Microbiome After Gastrectomy (NCT03418428) | Vilnius University | 2018-04-01 |
| The Criteria for Lymph Node Sorting for Pathological Examination in Gastric Cancer (NCT03478449) | Tianjin Medical University Cancer Institute and Hospital | 2018-04-01 |
| GlobalSurg 3: Quality and Outcomes in Global Cancer Surgery (NCT03471494) | University of Edinburgh | 2018-04-01 |
| Checkpoint Inhibitor and Radiotherapy for Recurrent Gastric Cancer (CIRCUIT) (NCT03453164) | Fukushima Medical University | 2018-03-28 |
| Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With TS-1+Cisplatin or TS-1+Oxaliplatin as First Line Chemotherapy in Gastric Cancer (MK-3475-659/KEYNOTE-659) (NCT03382600) | Merck Sharp & Dohme LLC | 2018-03-26 |
| A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites (NCT03475615) | Fudan University | 2018-03-16 |
| Comparing the Quality of Life Between LADG and TLDG for Gastric Cancer_KLASS07 (CKLASS01)). (NCT03393182) | Korea University Anam Hospital | 2018-03-01 |
| Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma (NCT03409848) | AIO-Studien-gGmbH | 2018-03-01 |
| Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies (NCT03638206) | Shenzhen BinDeBio Ltd. | 2018-03-01 |
| Prehabilitation in Patients With Esophageal or Gastric Cancers (NCT03418298) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2018-02-27 |
| Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients (NCT03342417) | ExcellaBio LLC | 2018-02-14 |
| A Study of HIPEC Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells (NCT03428425) | Hebei Medical University | 2018-02-01 |
| Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer (NCT03598348) | Huazhong University of Science and Technology | 2018-01-16 |
| Real World Evidence for the Cycle of Neoadjuvant Chemotherapy in Gastric Cancer With Shared Decision Making (NCT03413514) | Peking University | 2018-01-03 |
| Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancer (NCT04345783) | Beijing Friendship Hospital | 2018-01-01 |
| Gastric Cancer Prevention for Indigenous Peoples (NCT03900910) | National Taiwan University Hospital | 2018-01-01 |
| Use of a Liquid Biopsy Signature to Detect Early-onset Gastric Cancer (NCT06023121) | Chinese PLA General Hospital | 2018-01-01 |
| Neo-adjuvant Chemotherapy Evluation in Gastric Cancer Patients Based on Circulating Exosomal LncRNA-GC1 (NCT05647941) | Chinese PLA General Hospital | 2018-01-01 |
| Comparative Study of Antiperistaltic vs Isoperistaltic Billroth II + Braun Anastomosis for Postoperative Reflux (NCT03372681) | Shanghai Minimally Invasive Surgery Center | 2018-01-01 |
| Comparison of the Effect of Intravenous and Perineural Dexmedetomidine in Gastric Cancer Surgery (NCT03393403) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2017-12-23 |
| Multicentric Randomised Trial for Resectable Gastric Cancer (NCT02931890) | The Netherlands Cancer Institute | 2017-12-21 |
| Peritoneal Lavage for Early Detecting Gene Mutation of Peritoneal Metastasis of Gastric Cancer (NCT03314649) | Fudan University | 2017-12-21 |
| Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor (NCT03399253) | Sun Yat-sen University | 2017-12-10 |
| A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies (NCT03329950) | Celldex Therapeutics | 2017-12-01 |
| Web-Mediated Risk Assessment for Endoscopic Screening of Gastric Cancer (NCT03484949) | State Key Laboratory of Cancer Biology | 2017-12-01 |
| Incidence of Pancreatic Fistula After Radical Gastrectomy (NCT03391687) | Shanghai Zhongshan Hospital | 2017-12-01 |
| A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer (NCT03343301) | Five Prime Therapeutics, Inc. | 2017-11-30 |
| Perioperative Chemo and Pembrolizumab in Gastric Cancer (NCT02918162) | Gulam Manji | 2017-11-25 |
| Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer (NCT03425058) | Peking University Cancer Hospital & Institute | 2017-11-22 |
| Accuracy of Continuous and Non-invasive Hemoglobin Monitoring (NCT03957460) | Ajou University School of Medicine | 2017-11-20 |
| XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC) (NCT03399110) | Fudan University | 2017-11-17 |
| High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Gastroscopy Sedated by Propofol (NCT03332433) | RenJi Hospital | 2017-11-10 |
| Uncut Roux-en-Y vs Roux-en-Y (NCT03349398) | Jilin University | 2017-11-10 |
| Prediction of Benefit From Adjuvant Chemotherapy for pT1N1 Gastric Cancer (NCT03485105) | Yonsei University | 2017-11-01 |
| A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on First or Subsequent Line Therapies (NCT03321630) | NYU Langone Health | 2017-10-24 |
| Trial on Impact on the Hospital Stay, of an Early Oral Nutrition Protocol Applied to Patients After Total Gastrectomy. (DOPGT_2015) (NCT03257280) | Hospital Universitari de Bellvitge | 2017-10-20 |
| A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors (NCT03129139) | Minneamrita Therapeutics LLC | 2017-10-10 |
| Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient (NCT03196791) | Korea University Anam Hospital | 2017-10-10 |